Inspira Pharmaceuticals is focused on developing targeted therapies for respiratory diseases through advanced drug formulation and delivery systems. The company aims to improve patient outcomes by addressing the unmet medical needs in the treatment of chronic respiratory conditions.
Funding
$519.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current treatments for chronic respiratory diseases often fail to deliver medication effectively to the affected areas of the lungs, leading to suboptimal therapeutic outcomes and increased side effects. Many existing drug formulations also lack the necessary properties for targeted delivery and sustained release in the respiratory system.
Solution
Inspira Pharmaceuticals develops targeted therapies for respiratory diseases using advanced drug formulation and delivery systems. The company focuses on improving drug delivery to the lungs by creating innovative formulations that enhance penetration and residence time in the respiratory tract. Their technology aims to optimize drug release kinetics, reduce systemic exposure, and improve the overall efficacy of treatments for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. By addressing the limitations of conventional drug delivery methods, Inspira Pharmaceuticals seeks to provide more effective and patient-friendly therapeutic options for respiratory illnesses.
Target Audience
The primary target audience includes pharmaceutical companies seeking to enhance their respiratory drug pipelines, as well as healthcare providers and patients with chronic respiratory conditions.
Features
- Proprietary drug formulation technology for enhanced aerosolization and deep lung penetration
- Sustained-release microsphere technology for prolonged therapeutic effect and reduced dosing frequency
- Targeted drug delivery systems that selectively deliver medication to specific lung tissues
- Optimized formulations for use with various inhalation devices, including nebulizers, metered-dose inhalers, and dry powder inhalers